PPARG and cancer: One possible reason behind that confliction is that some ARBs, such as telmisartan, are able to activate the Peroxisome Proliferator-Activated Receptor-gamma’s (PPAR-γ) signalling, which controls the proliferation of cancer and promotes apoptosis.